Biomarker-Driven Lung Cancer Care: Application of New Standards and the Latest Research

Download All
Deepen your understanding of the role of biomarkers in lung cancer treatment and learn how to apply recent biomarker data from key clinical trials in a webcast from a live symposium, with associated downloadable slides and an expert commentary.
Todd M. Bauer, MD
Narjust Duma, MD
Karen L. Reckamp, MD, MS

On-Demand Webcast

In this on-demand webcast from a live symposium, oncology experts Todd M. Bauer; MD, Narjust Duma, MD; and Karen L. Reckamp, MD, MS discuss current and emerging data on biomarker testing and targeted therapy for the treatment of patients with NSCLC.

Todd M. Bauer, MD Narjust Duma, MD Karen L. Reckamp, MD, MS Physicians: maximum of 1.75 AMA PRA Category 1 Credits™ Released: June 7, 2022 Expired: No longer available for credit
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Amgen
Lilly
Novartis Pharmaceuticals Corporation
Turning Point Therapeutics, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings